November 14, 2014 - Today is World Diabetes Day. Globally, 382 million people were living with diabetes in 2013. In 2035, it is estimated that 592 million people will be living with diabetes, a 55% increase from today1.
In sub-Saharan Africa, non-communicable diseases like diabetes are on the rise2. However, many African countries are ill-prepared to deal with these new healthcare challenges2.
In Ethiopia, Sandoz has initiated a new project called Sandoz Executive Medical Management Academy (SEMMA), an educational program for local healthcare professionals. Last week (Nov. 3 – 7), Sandoz hosted the first in a series of modules which focused on diabetes.
“Diabetes is essentially unknown in Ethiopia,” said Ludmilla Reina, Sandoz Country Head of Ethiopia. “We are working with different medical professional associations to current medical information and best practice with healthcare providers here. It is our aim to contribute to building and updating skills locally.”
According to 2013 sales and market data, Sandoz has a portfolio of approximately 1,100 molecules, and holds the #1 position globally in biosimilars as well as in generic injectables, ophthalmics, dermatology and antibiotics, complemented by leading positions in the cardiovascular, metabolism, central nervous system, pain, gastrointestinal, respiratory, and hormonal therapeutic areas.
1 According to the data of analytical company Morion (January-August, 2014) 2 Economist Intelligence Unit, Sub-Saharan African healthcare: the user experience, A focus on non-communicable diseases, 2014.